On the horizon: newly-developed quality improvement projects. Florida Medical Quality Assurance, Inc.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002121:Calcium Channel Blockers; D000075202:Contraindications; D005431:Florida; D006279:Health Maintenance Organizations; D006801:Humans; D006278:Medicare; D009203:Myocardial Infarction / Q000628:therapy*; D017063:Outcome Assessment, Health Care; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011785:Quality Assurance, Health Care; D012189:Retrospective Studies; D016540:Smoking Cessation; D015912:Thrombolytic Therapy; D014481:United States
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin